Exosomes and exosomal miRNAs in cardiovascular protection and repair

Vascular Pharmacology

Volumn 71, Issue , 2015, Pages 24-30

  Emanueli, Costanza ^a,b   Shearn, Andrew I U ^a   Angelini, Gianni D ^a,b   Sahoo, Susmita ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Cardiac protection; Exosomes; Ischemia; Ischemia reperfusion injury; MicroRNAs; Stem cells

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; LIPID; MICRORNA;

ANGIOGENESIS; BIOGENESIS; CARDIOVASCULAR DISEASE; CELL COMMUNICATION; CELL SIZE; CONFOCAL MICROSCOPY; DEVELOPMENTAL BIOLOGY; ELECTRON MICROSCOPY; EXOSOME; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEART PROTECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID TRANSPORT; NONHUMAN; PARTICLE SIZE; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW; RNA TRANSPORT; STEM CELL; ANIMAL; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BIOMARKERS; CARDIOVASCULAR DISEASES; CELL COMMUNICATION; CELL DIFFERENTIATION; EXOSOMES; HUMANS; MICRORNAS;

EID: 84937977362     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.02.008     Document Type: Review

References (60)

1. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26(4):239-257.
2. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007, 35:495-516.
3. Witwer K.W., et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J extracellular vesicles 2013, 2:1-25.
4. Skokos D., et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol 2003, 170:3037-3045.
5. Malik Z.A., et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol 2013, 304:H954-H965.
6. Valadi H., et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9(6):654-659.
7. Villarroya-Beltri C., et al. Sorting it out: regulation of exosome loading. Semin Cancer Biol 2014, 28:3-13.
8. Sahoo S., et al. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res 2011, 109(7):724-728.
9. Oksvold M.P., et al. Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells. Clin Ther 2014, 36(6):847-862. [e1].
10. Zakharova L., Svetlova M., Fomina A.F. T cell exosomes induce cholesterol accumulation in human monocytes via phosphatidylserine receptor. J Cell Physiol 2007, 212(1):174-181.
11. Palma J., et al. MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Res 2012, 40(18):9125-9138.
12. Tauro B.J., et al. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics 2013, 12(3):587-598.
13. Fader C.M., et al. TI-VAMP/VAMP7 and VAMP3/cellubrevin: two v-SNARE proteins involved in specific steps of the autophagy/multivesicular body pathways. Biochim Biophys Acta 2009, 1793(12):1901-1916.
14. O'Loughlin A.J., Woffindale C.A., Wood M.J. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther 2012, 12(4):262-274.
15. Fitzner D., et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci 2011, 124(Pt 3):447-458.
16. Parolini I., et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009, 284(49):34211-34222.
17. Segura E., et al. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 2007, 179(3):1489-1496.
18. Villarroya-Beltri C., et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun 2013, 4:2980.
19. Shantikumar S., Angelini G.D., Emanueli C. Diabetes, microRNAs and exosomes: Les liaisons dangereuses. J Mol Cell Cardiol 2014, 74:196-198.
20. Bang C., et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 2014, 124(5):2136-2146.
21. Ong S.G., et al. Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer. Circulation 2014, 130(11 Suppl 1):S60-S69.
22. Gray W.D., et al. Identification of therapeutic covariant microRNA clusters in hypoxia treated cardiac progenitor cell exosomes using systems biology. Circ Res 2015, 116(2):255-263.
23. Feng Y., et al. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One 2014, 9:e88685.
24. Cheng M., et al. Circulating exosomal miR-1a is markedly induced by myocardial infarction and downregulates CXCR4 expression in the bone marrow mononuclear cells. American Heart Association Scientific Sessions 2014, Lippincott Williams & Wilkins, United States (http://circ.ahajournals.org/content/130/Suppl_2/A18383.abstract).
25. Arslan F., et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 2013, 10:301-312.
26. Théry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nature reviews. Immunology 2009, 9:581-593.
27. van Weering J.R.T., et al. Intracellular membrane traffic at high resolution. Methods Cell Biol 2010, 96:619-648.
28. Février B., Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004, 16:415-421.
29. Gardiner C., et al. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J extracell vesicles 2013, 2.
30. Dragovic R.A., et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomed Nanotechnol Biol Med 2011, 7:780-788.
31. Malvern Dynamic light scattering: an introduction in 30minutes (cited 2014 29/07/2014; Available from). http://www.malvern.com/en/support/resource-center/technical-notes/TN101104DynamicLightScatteringIntroduction.aspx.
32. van der Pol E., et al. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost 2012, 10(5):919-930.
33. Ostrowski M., et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010, 12:19-30. [sup pp 1-13].
34. van der Vlist E.J., et al. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry. Nat Protoc 2012, 7(7):1311-1326.
35. Lugini L., et al. Immune surveillance properties of human NK cell-derived exosomes. J Immunol 2012, 189:2833-2842. (Baltimore, Md.: 1950).
36. Sharma S., et al. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano 2010, 4(4):1921-1926.
37. Tatischeff I., et al. Fast characterisation of cell-derived extracellular vesicles by nanoparticles tracking analysis, cryo-electron microscopy, and Raman tweezers microspectroscopy. J Extracell Vesicles 2012, 1:19179.
38. van der Pol E., et al. Innovation in detection of microparticles and exosomes. J Thromb Haemost 2013, 11(Suppl. 1):36-45.
39. van der Pol E., et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost 2014, 12(7):1182-1192.
40. Akyurekli C., et al. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev 2015, 11(1):150-160.
41. Lamichhane T.N., et al. Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. Tissue Eng Part B Rev 2015, 21(1):45-54.
42. Barile L., et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res 2014, 103(4):530-541.
43. Hergenreider E., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012, 14(3):249-256.
44. Wang X., et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol 2014, 74:139-150.
45. Leroyer A.S., et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007, 49(7):772-777.
46. Giricz Z., et al. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol 2014, 68:75-78.
47. Katare R., et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 2011, 109(8):894-906.
48. Sahoo S., Losordo D.W. Exosomes and cardiac repair after myocardial infarction. Circ Res 2014, 114(2):333-344.
49. Mackie A.R., et al. Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ Res 2012, 111(3):312-321.
50. Mocharla P., et al. AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. Blood 2013, 121(1):226-236.
51. Chen T.S., et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 2010, 38(1):215-224.
52. Lai R.C., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010, 4(3):214-222.
53. Ibrahim A.G., Cheng K., Marban E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep 2014, 2(5):606-619.
54. Chen L., et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys Res Commun 2013, 431:566-571.
55. Campagnolo P., et al. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 2010, 121(15):1735-1745.
56. Alvarez-Erviti L., et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29(4):341-345.
57. El-Andaloussi S., et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 2012, 7(12):2112-2126.
58. Rountree R.B., et al. Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy. Cancer Res 2011, 71(15):5235-5244.
59. Skog J., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10(12):1470-1476.
60. Taylor D.D., Homesley H.D., Doellgast G.J. "Membrane-associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients. Am J Reprod Immunol 1983, 3(1):7-11.